文献速递前列腺癌

DNMT3B基因单核苷酸多态性及mRNA表达与前列腺癌死亡率的关系

Single-nucleotide polymorphisms in DNMT3B gene and DNMT3B mRNA expression in association with prostate cancer mortality.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2018-10-19

研究纳入两个意大利队列和两个美国队列的前列腺癌患者,评估DNMT3B三个变异与全球DNA甲基化及前列腺癌死亡率的关系,并分析DNMT3B mRNA表达与致死性前列腺癌的关联。结果显示DNMT3B变异与前列腺癌死亡率无一致关联,但rs1569686的TT基因型与肿瘤组织LINE-1低甲基化相关,DNMT3B mRNA表达与致死性前列腺癌风险升高相关并在公共数据库复制。

要点

  • DNMT3B三个选定变异与前列腺癌死亡率无一致关联证据。
  • rs1569686 TT基因型与肿瘤组织LINE-1低甲基化相关(β=-2.71,95%CI:-5.41,-0.05)。
  • DNMT3B mRNA表达与致死性前列腺癌风险升高相关,并在TCGA和MSKCC数据中复制。

核心结论

  • DNMT3B变异与前列腺癌死亡率无一致关联证据,但rs1569686 TT基因型与肿瘤组织LINE-1低甲基化相关,DNMT3B mRNA表达与致死性前列腺癌风险升高相关。

研究设计与样本

  • 研究涉及两个意大利队列(NTAT队列n=157,1980年代活检队列n=182)和两个美国队列(健康专业人员随访研究n=214,医师健康研究n=298)的前列腺癌患者。
  • 另嵌套于美国队列的病例对照研究比较致死性(n=113)与惰性(n=290)前列腺癌的DNMT3B mRNA表达。
  • 在NTAT队列中用线性回归评估三个DNMT3B变异与全球DNA甲基化的关联。
  • 在所有队列中用Cox比例风险回归评估三个DNMT3B变异与前列腺癌死亡率的关联。
  • 用逻辑回归评估DNMT3B表达与致死性前列腺癌的关联,并在公共数据库(TCGA n=492,MSKCC n=140)中复制。

主要发现

  • rs1569686的TT基因型与肿瘤组织LINE-1低甲基化相关(β=-2.71,95%CI:-5.41,-0.05)。
  • 未发现DNMT3B变异与前列腺癌死亡率之间存在关联的证据。
  • 在两个美国队列中,DNMT3B表达与致死性前列腺癌一致相关(第三分位 vs 第一分位,合并队列:OR=2.04,95%CI:1.13,3.76)。
  • 该关联在TCGA和MSKCC数据中复制(第三分位 vs 第一分位,TCGA:HR=3.00,95%CI:1.78,5.06;MSKCC:HR=2.22,95%CI:1.01,4.86)。

临床怎么用

  • DNMT3B mRNA表达可能作为致死性前列腺癌的风险分层参考,但需进一步验证。
  • rs1569686 TT基因型与LINE-1低甲基化的关联提示其潜在生物学意义,但不足以用于临床决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Germline variants in DNA methyltransferase 3B (DNMT3B) may influence DNMT3B enzymatic activity, which, in turn, may affect cancer aggressiveness by altering DNA methylation. METHODS: The study involves two Italian cohorts (NTAT cohort, n = 157, and 1980s biopsy cohort, n = 182) and two U.S. cohorts (Health Professionals Follow-Up Study, n = 214, and Physicians' Health Study, n = 298) of prostate cancer (PCa) patients, and a case-control study of lethal (n = 113) vs indolent (n = 290) PCa with DNMT3B mRNA expression data nested in the U.S. cohorts. We evaluated the association between: three selected DNMT3B variants and global DNA methylation using linear regression in the NTAT cohort, the three DNMT3B variants and PCa mortality using Cox proportional hazards regression in all cohorts, and DNMT3B expression and lethal PCa using logistic regression, with replication in publicly available databases (TCGA, n = 492 and MSKCC, n = 140). RESULTS: The TT genotype of rs1569686 was associated with LINE-1 hypomethylation in tumor tissue (β = -2.71, 95% CI: -5.41, -0.05). There was no evidence of association between DNMT3B variants and PCa mortality. DNMT3B expression was consistently associated with lethal PCa in the two U.S. cohorts (3rd vs 1st tertile, combined cohorts: OR = 2.04, 95% CI: 1.13, 3.76); the association was replicated in TCGA and MSKCC data (3rd vs 1st tertile, TCGA: HR = 3.00, 95% CI: 1.78, 5.06; MSKCC: HR = 2.22, 95% CI: 1.01, 4.86). CONCLUSIONS: Although there was no consistent evidence of an association between DNMT3B variants and PCa mortality, the TT genotype of rs1569686 was associated with LINE-1 hypomethylation in tumor tissue and DNMT3B mRNA expression was associated with an increased risk of lethal PCa.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Zelic R, Fiano V, Ebot EM, et al. Single-nucleotide polymorphisms in DNMT3B gene and DNMT3B mRNA expression in association with prostate cancer mortality. Prostate Cancer Prostatic Dis. 2018. PMID: 30341411. doi:10.1038/s41391-018-0102-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。